Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies
A basis for updating our approach to resistant acute leukemia
Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma
A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
Sorafenib, a multikinase inhibitor, is effective in vitro against non-hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin
Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management
An uncommon morphological variant of acute promyelocytic leukemia
If at first you don't succeed: Try, try again
BCR-ABL1 kinase domain mutations: Methodology and clinical evaluation
Pyrazinamide-induced sideroblastic anemia
Fatal disseminated intravascular coagulation in acute promyelocytic leukemia
Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron
Leukocyte adhesion deficiency-I variant syndrome (LAD-Iv, LAD-III): Molecular characterization of the defect in an index family
A case of factor V inhibitor with complete correction of the PT and aPTT upon mixing
Trends in anti-D immune globulin for childhood immune thrombocytopenia: Usage, response rates, and adverse effects
Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia
Circulating endothelial cells and endothelial activation in essential thrombocythemia: Results from CD146+ immunomagnetic enrichment—flow cytometry and soluble E-selectin detection
Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab
Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia
Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates
Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: A pooled analysis of 15 prospective studies
Inpatient management of sickle cell pain: A ‘snapshot’ of current practice
Imatinib mesylate for lymphocytic variant of hypereosinophilic syndrome
Imatinib mesylate for lymphocytic variant of hypereosinophilic syndrome: A response
More definitions in sickle cell disease: Steady state v base line data
Drug interaction between lenalidomide and itraconazole
Framing the research agenda for sickle cell trait: Building on the current understanding of clinical events and their potential implications